Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,367,675
+$243,927 QoQ
Shares Held
1,974
-14.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#2,344
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global X Japan Co., Ltd. holds $85,923,287 across 8 Drug Manufacturers - General names. LLY ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
119,340 | $30,030,717 | |
| 2 | JNJ |
Johnson & Johnson
|
83,998 | $21,332,972 | |
| 3 | AMGN |
Amgen Inc
|
27,085 | $9,808,020 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,680 | $9,467,880 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
60,937 | $7,698,780 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
90,137 | $5,193,693 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
1,974 | $2,367,675 | |
| 8 | BIIB |
Biogen Inc.
|
109 | $23,550 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,367,675 | 1,974 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,123,748 | 2,309 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,267,575 | 2,110 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,402,394 | 1,838 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,667,414 | 2,139 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,712,937 | 2,074 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,793,356 | 2,323 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $2,315,847 | 2,614 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,139,412 | 2,363 | Shares | Defined | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||